Stay updated on Psilocybin for Depression in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.

Latest updates to the Psilocybin for Depression in Early Alzheimer's Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed descriptions of a pilot study on psilocybin for depression in patients with Mild Cognitive Impairment or early Alzheimer's Disease, while retaining some information about the study's location and collaborators.SummaryDifference35%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Psilocybin for Depression in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.